Can lifestyle changes have an impact on breast cancer outcomes?

Written by: Dr Shiroma De Silva-Minor
Published:
Edited by: Conor Dunworth

In her latest online article, renowned consultant medical and clinical oncologist Dr Shiroma De Silva-Minor offers her expert insight into the lifestyle changes you can make to improve breast cancer outcomes, as well as your health in general.  

 

Can lifestyle have an impact on breast cancer outcomes?

As a breast oncologist, I strongly believe that lifestyle changes can improve breast cancer outcomes and overall health for my patients. There is strong evidence to suggest that adopting a healthy lifestyle, including regular exercise, a balanced diet, and stress reduction techniques, can help reduce the risk of breast cancer recurrence and improve overall health.

 

What role does exercise play?

Regular exercise has been shown to improve physical function and quality of life, and may also reduce the risk of recurrence in breast cancer patients. A study found that breast cancer patients who engaged in regular moderate-intensity exercise had a lower risk of cancer recurrence and improved survival rates.

 

Regular exercise also helps counteract some of the adverse effects of treatment. For example, anthracycline chemotherapy commonly used to treat breast cancer as well as radiotherapy to the breast (particularly left-sided treatment) can increase the risk of ischaemic heart disease. Premature menopause or anti-oestrogen therapy with Aromatase inhibitors can cause bone thinning and increase the risk of osteoporosis and fractures.  A healthy lifestyle and regular exercise (particularly cardiovascular or weight-bearing) can help optimise both heart and bone health.

 

What role does diet play?

A balanced diet that includes a variety of nutrient-rich foods, such as fruits, vegetables, whole grains, and lean protein, can help maintain a healthy weight and reduce the risk of chronic diseases, including breast cancer. Some research suggests that following a plant-based diet may have additional benefits for breast cancer patients, although more research is needed to confirm this. Reducing saturated animal fats has many established health benefits such as reducing the risk of cardiovascular disease, and certain cancers such as breast and colon cancers and aiding healthy weight maintenance, and would be advisable in any case. When reducing saturated fats in the diet, it's important to replace them with healthier fats, such as monounsaturated and polyunsaturated fats found in foods like nuts, seeds, avocados, and fatty fish.

 

Can stress affect breast cancer outcomes?

Stress reduction techniques, such as meditation and yoga, may help improve mental and emotional well-being and reduce stress levels, which can have a positive impact on overall health and potentially improve cancer outcomes.

 

Can lifestyle changes replace traditional cancer treatments?

It is vitally important that lifestyle changes should not be used as an alternative to evidence-based, gold-standard breast cancer treatment, such as surgery, chemotherapy, radiotherapy, endocrine therapy and other systemic therapies. However, adopting a healthy lifestyle can complement standard treatment and may help improve overall health and reduce the risk of cancer recurrence.  I believe in empowering my patients to make healthy lifestyle changes and providing support and guidance to help them achieve their goals.

 

Dr Shiroma De Silva Minor is a highly-revered consultant medical and clinical oncologist based in London, Oxford and Swindon, with over 25 years of experience. You can book a consultation today on her Top Doctors profile.

By Dr Shiroma De Silva-Minor
Medical oncology

Dr Shiroma De Silva-Minor is an accomplished and experienced consultant breast oncologist who specialises in breast cancer (both male and female), breast screening, chemotherapy, radiotherapy, immunotherapy, intraoperative radiation therapy, inflammatory breast cancers, HER2 positive disease, triple-negative breast cancers and breast cancer in pregnancy.

Dr De Silva-Minor oversees the entire (non-surgical) breast cancer pathway so she can advise on all aspects of treatment, including genetic counselling and testing, systemic (chemo) therapy, radiotherapy, and lifestyle factors in optimising health and minimising disease recurrence. Dr De Silva-Minor is currently practising privately, at the London-based Cromwell Hospital, as well as at GenesisCare Oxford, at The Chiltern Hospital, and as an NHS Consultant at the Oxford University Hospitals NHS Foundation Trust, Oxford.

Dr De Silva-Minor, whose clinical expertise is in the treatment of early and recurrent breast cancer, notably obtained her first medical qualification in 1995, with her medical doctorate from the prestigious Cardiff-based University of Wales College of Medicine. In 1999, Dr De Silva-Minor was awarded the membership of the Royal College of Physicians (UK). Dr De Silva-Minor pursued her specialist oncology training at several centres of oncological excellence in London, including The Middlesex Hospital, The Royal Free Hospital, as well as The Royal Marsden Hospital, amongst others.

In 2003, Dr De Silva-Minor was awarded the fellowship of the Royal College of Radiologists and was also recognised as a clinical oncology specialist on the General Medical Council's register in 2007. Dr De Silva-Minor has been a consultant oncologist since 2007 and was appointed as a substantive consultant oncologist by the Oxford University Hospitals NHS Foundation Trust in 2008.

Dr De Silva-Minor has published extensively in peer-reviewed journals. During a fellowship in head and neck radiation oncology at The Princess Margaret Hospital in Toronto, Canada, Dr De Silva-Minor was awarded the Prize for Academic Excellence by the Princess Margaret Hospital and the University of Toronto for her research into the use of PETCT scans (Positron Emission Tomography) when identifying head and neck tumours for treatment with radiotherapy. Dr De Silva-Minor is a member of the breast cancer expert panel for the National Institute of Health and Clinical Excellence (NICE), updating clinical guidelines on breast cancer management.

Dr De Silva-Minor is also collaborating on a metanalysis with the Early Breast Cancer Trialists' Collaborative Group (EBCTCG) to bring together the research on radiotherapy clinical trials to better understand how to optimally treat breast cancer patients with radiotherapy. Dr De Silva-Minor is a member of the Advisory Board on Cancer in Pregnancy (ABCIP), an international panel of experts in managing breast cancer in pregnancy. Dr De Silva-Minor is a passionate advocate for empowering her patients to be involved in their management decisions. Treatment is completely bespoke to individual patients, their specific tumour subtype, taking into consideration the individual's beliefs, wishes and personal circumstances.

View Profile

Overall assessment of their patients


  • Related procedures
  • Mouth cancer
    Prostate cancer
    Human papillomavirus (HPV)
    Human papillomavirus vaccine (HPV)
    Breast cancer
    Brain tumour
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Doppler Ultrasound
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.